Elicio Therapeutics Inc (ELTX)
9.70
+0.32
(+3.41%)
USD |
NASDAQ |
May 20, 15:48
Elicio Therapeutics Shares Outstanding: 10.22M for March 26, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
| Date | Value |
|---|---|
| March 26, 2024 | 10.22M |
| March 18, 2024 | 10.22M |
| December 31, 2023 | 9.604M |
| December 22, 2023 | 9.606M |
| November 07, 2023 | 8.407M |
| Date | Value |
|---|---|
| September 30, 2023 | 8.378M |
| August 10, 2023 | 8.388M |
| June 30, 2023 | 8.370M |
| June 02, 2023 | 8.732M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
8.370M
Minimum
Jun 30 2023
10.22M
Maximum
Mar 18 2024
9.103M
Average
8.732M
Median
Jun 02 2023
Shares Outstanding Benchmarks
| Immuneering Corp | 29.65M |
| Outlook Therapeutics Inc | 23.41M |
| Amylyx Pharmaceuticals Inc | 68.01M |
| NovaBay Pharmaceuticals Inc | 37.83M |
| Palatin Technologies Inc | 16.14M |